Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma

Tas F., Bilgin E., Karabulut S., Erturk K., Duranyildiz D.

BBA CLINICAL, cilt.5, ss.166-169, 2016 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.bbacli.2016.04.001
  • Dergi Adı: BBA CLINICAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.166-169
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Protease-Activated Receptor-1 (PAR-1) plays an important role in the pathogenesis of multiple malignancies and its expression strongly also affects the outcomes of cancer patients. The objective of this study was to determine the clinical significance of the serum levels of PAR-1in cutaneous melanoma patients.